Kirk Schroeder

Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA.

Biomatrica, Inc. produces reagents and devices used for sample collection and analysis in diagnostics systems, nucleic acid analysis, and bio banking. Its technology is used to protect analyst in samples at the molecular and cellular level, chemically position laboratory workflows on microfluidics chips. The firm’s products include DNAstable, DNAgard, RNAstable and RNAgard. The company was founded by Judy L. Müller-Cohn and Rolf Müller in 2004 and is headquartered in San Diego, CA.

IROA Technologies LLC provides chemical signatures in biological compounds. Its products include IROA 100: Yeast and Fungi Profiling, IROA 200: Bacterial Profiling, IROA 300: Mammalian Profiling, IROA Phenotypic Quantitation Kit, IROA Fluxomic Quantitation Kit, Unlabeled IROA Mammalian Media, Unlabeled IROA Bacterial Media and Dialyzed Fetal Bovine Serum. The company was founded by Chris Beecher and Felice A. de Jong in June 2010 and is headquartered in Bolton, MA.

Oricula Therapeutics LLC develops medication to prevent hearing loss. Its products is ORC-13661, a medicine to preserve hearing during aminoglycoside therapy, has completed preclinical development and has been approved to move into early human testing for safety, tolerability and pharmacokinetics. The company was founded in 2013 and is headquartered in Seattle, WA.

Biocare Medical LLC develops and supplies automated immunohistochemistry instrumentation and reagents for IHC lab testing. It offers simultaneous Multiplex IHC and antibody development, which aids in the assessment of clinical cases and accelerates turnaround time. The company was founded by Gene J. Castagnini, David E. Tacha and Roy Paxton Yih in 1997 and is headquartered in Concord, CA.

Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA.

NanoCellect Biomedical, Inc. develops flow cytometry and cell sorting technology solutions for life science researchers to perform cellular analysis, develop molecular diagnostics, and improve personalized medicine. Its products include wolf cell sorter and N1 single cell dispenser. The company was founded by Nate Heintzman and Yuhwa Lo in 2009 and is headquartered in San Diego, CA.

Slingshot Biosciences, Inc. is a life sciences company that develops synthetic cells for various applications in diagnostics and therapeutics. The company is based in Emeryville, CA. The company utilizes advances in distributed manufacturing, engineering, and polymer chemistry to provide an industry-first, off-the-shelf solution for cell-like reagents that are stable, low-cost, and targeted towards a range of indications and markets. Slingshot Biosciences focuses on developing cutting-edge tools for fluorescence imaging to revolutionize how scientists explore and understand the intricate mechanisms of life. The company is committed to empowering researchers with exceptional products that enable groundbreaking discoveries and shape the future of bioscience. The company was founded in 2012 by Jeffrey Kim, who has been the CEO since 2012.

Semarion Ltd. is a technology company based in Cambridge, UK. Semarion is revolutionizing cell screening with a unique assaying microcarrier platform. The British company was founded by Jeroen Verheyen and Tarun Vemulkar, with Jeroen Verheyen serving as the CEO since incorporation.

GENEWIZ, Inc. provides research and development genomics services. Its services include Sanger deoxyribonucleic acid (DNA) sequencing, gene synthesis, next generation sequencing, molecular genetics, cloning and mutagenesis, plasmid DNA preparation, and good laboratory practice (GLP)-compliant services. The company was founded by Amy Liao and Steve Sun in 1999 and is headquartered in South Plainfield, NJ.